Institute of Cancer Sciences
Part of the University of Glasgow's College of Medical, Veterinary & Life Sciences
The Institute of Cancer Sciences is part of a national centre of excellence in the fight against cancer. We carry out a programme of world-class science directed at understanding the molecular changes that cause cancer. We are working to translate scientific discoveries into new drugs or diagnostic and prognostic tools that benefit cancer patients, taking new therapies through preclinical and clinical trials. The Institute of Cancer Sciences is a major component of the Cancer Research UK West of Scotland Cancer Centre.
Glasgow Tissue Research Facility
The Glasgow Tissue Research Facility (GTRF) works closely with NHSGGC Bio-repository which provides researchers access to a wide variety of consented tissue:
- Pathology archive samples
- Surplus diagnostic or surgical tissue
- Bespoke collections of tissue from NHS Scotland patients may have been/or can be collected as part of cohort studies or clinical trials.
OracleBio is a global leader in quantitative digital pathology, providing image analysis services to Pharma and Biotech clients worldwide. Leveraging multiple software platforms, the company delivers robust data packages within a quality management framework, to support clinical trials and translational research. As image analysis experts, OracleBio specialises in cellular phenotyping of multiplex stained tissue and have built an enviable reputation as the go-to company for complex image analysis
Canon Medical Research Europe Ltd
BioClavis, LTD is a Glasgow-based personalized diagnostics spin-out of US-based biotechnology company—BioSpyder Technologies, Inc. Utilising the novel transcriptomic/genomic platform technology (TempO-Seq®), to provide targeted-sequencing technology capable of efficiently analysing large cohorts with customizable biomarker panels of tens to thousands of genes, quickly and inexpensively. We work within the space of drug discovery, toxicology, and personalised diagnostics delivering cost-effective care for individual patients in coordination with and in the context of evolving and expanding healthcare systems. BioClavis operates from its R&D and services laboratories situated within the Clinical Innovation Zone at the Queen Elizabeth University Hospital, working with large consortia, Pharma, Academia and clinical research partners.
NHS Greater Glasgow and Clyde
NHS Greater Glasgow and Clyde (NHSGGC) is one of 14 regional NHS Boards in Scotland.
The Board provides strategic leadership and performance management for the entire local NHS system in the Greater Glasgow and Clyde area and ensures that services are delivered effectively and efficiently. Responsible for the provision and management of the whole range of health services in this area including hospitals and General Practice, NHSGGC works alongside partnership organisations including Local Authorities and the voluntary sector. NHSGGC serves a population of 1.14 million and employs around 39,000 staff – it is the largest NHS organisation in Scotland and one of the largest in the UK.